Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,929,718 shares
Latest Disclosed Value $ 44,970,641
Geode Capital Management, Llc reports 10.12% increase in ownership of HVE / Innoviva, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,929,718 shares of Innoviva, Inc. (DE:HVE) valued at $38,594,360 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,752,438 shares of Innoviva, Inc.. This represents a change in shares of 10.12% during the quarter. The current value of the position is $37,050,586 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 1,929,718 177,280 10.12 44,971 28.35 0.0015
2026-02-09 2025-12-31 13F INNOVIVA COM 45781M101 1,752,438 178,238 11.32 35,038 21.94 0.0022
2025-11-12 2025-09-30 13F INNOVIVA COM 45781M101 1,574,200 51,578 3.39 28,733 -6.08 0.0018
2025-08-08 2025-06-30 13F INNOVIVA COM 45781M101 1,522,622 102,194 7.19 30,593 18.77 0.0021
2025-05-13 2025-03-31 13F INNOVIVA COM 45781M101 1,420,428 63,292 4.66 25,758 9.37 0.0020
2025-02-12 2024-12-31 13F INNOVIVA COM 45781M101 1,357,136 -421 -0.03 23,552 -10.18 0.0018
2024-11-12 2024-09-30 13F INNOVIVA COM 45781M101 1,357,557 13,257 0.99 26,219 18.91 0.0021
2024-08-09 2024-06-30 13F INNOVIVA COM 45781M101 1,344,300 18,867 1.42 22,051 9.15 0.0019
2024-05-13 2024-03-31 13F INNOVIVA COM 45781M101 1,325,433 917,611 225.00 20,202 1,123.62 0.0019
2024-02-13 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 407,822 2,244 0.55 1,652 51.33 0.0002
2024-02-13 2023-12-31 13F INNOVIVA COM 45781M101 1,311,272 38,375 21,035 0.0022
2023-11-13 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 405,578 -15,944 -3.78 1,091 -72.25 0.0001
2023-11-13 2023-09-30 13F INNOVIVA COM 45781M101 1,272,897 7,548 16,537 0.0020
2023-08-11 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 421,522 93,652 28.56 3,933 35.07 0.0005
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 1,265,349 19,155 16,108 0.0019
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 327,870 28,264 9.43 2,911 291,000.00 0.0004
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 1,246,194 49,373 14,020 0.0018
2023-02-13 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 299,606 12,211 4.25 1 -99.94 0.0002
2023-02-13 2022-12-31 13F INNOVIVA COM 45781M101 1,196,821 46,886 16 0.0022
2022-11-14 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 287,395 31,256 12.20 1,666 17.66 0.0003
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 1,149,935 14,055 13,350 0.0020
2022-08-12 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 256,139 53,703 26.53 1,416 -39.33 0.0002
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 1,135,880 132,856 16,765 0.0025
2022-05-13 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 202,436 10,389 5.41 2,334 -4.15 0.0003
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 1,003,024 6,901 19,408 0.0024
2022-02-11 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 192,047 -797,732 -80.60 2,435 -85.28 0.0003
2022-02-11 2021-12-31 13F INNOVIVA COM 45781M101 996,123 6,344 17,183 0.0021
2021-11-12 2021-09-30 13F INNOVIVA COM 45781M101 989,779 -144,810 -12.76 16,539 8.71 0.0022
2021-08-13 2021-06-30 13F INNOVIVA COM 45781M101 1,134,589 -6,752 -0.59 15,214 11.55 0.0021
2021-05-12 2021-03-31 13F INNOVIVA COM 45781M101 1,141,341 135,244 13.44 13,639 9.42 0.0021
2021-02-12 2020-12-31 13F INNOVIVA COM 45781M101 1,006,097 32,274 3.31 12,465 22.49 0.0021
2020-11-13 2020-09-30 13F INNOVIVA COM 45781M101 973,823 -46,881 -4.59 10,176 -28.68 0.0020
2020-08-13 2020-06-30 13F INNOVIVA COM 45781M101 1,020,704 21,286 2.13 14,269 21.41 0.0031
2020-05-14 2020-03-31 13F INNOVIVA COM 45781M101 999,418 56,124 5.95 11,753 -12.01 0.0031
2020-02-20 2019-12-31 13F/A-1 INNOVIVA COM 45781M101 943,294 28,488 3.11 13,357 38.53 0.0028
2020-02-13 2019-12-31 13F INNOVIVA COM 45781M101 943,294 28,488 13,357 1,702.2325
2019-11-12 2019-09-30 13F INNOVIVA COM 45781M101 914,806 21,446 2.40 9,642 -25.87 0.0023
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 893,360 28,522 3.30 13,007 7.20 0.0031
2019-05-14 2019-03-31 13F INNOVIVA COM 45781M101 864,838 64,959 8.12 12,133 -13.07 0.0031
2019-03-06 2018-12-31 13F/A-1 INNOVIVA COM 45781M101 799,879 23,141 2.98 13,957 17.91 0.0043
2019-02-13 2018-12-31 13F INNOVIVA COM 45781M101 799,879 23,141 13,957
2018-11-13 2018-09-30 13F INNOVIVA COM 45781M101 776,738 26,887 3.59 11,837 14.40 0.0033
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 749,851 -4,562 -0.60 10,347 -17.72 0.0032
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 754,413 -36,996 -4.67 12,575 11.98 0.0041
2018-02-13 2017-12-31 13F INNOVIVA COM 45781M101 791,409 -8,792 -1.10 11,230 -0.60 0.0038
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 800,201 85,630 11.98 11,298 23.53 0.0042
2017-08-14 2017-06-30 13F INNOVIVA COM 45781M101 714,571 33,281 4.88 9,146 -2.93 0.0036
2017-06-21 2017-03-31 13F/A-1 INNOVIVA COM 45781M101 681,290 80,076 13.32 9,422 46.49 0.0039
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 681,290 9,422
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 601,214 21,537 3.72 6,432 0.97 0.0030
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 579,677 -7,199 -1.23 6,370 3.09 0.0032
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 586,876 10,586 1.84 6,179 -14.83 0.0034
2016-05-13 2016-03-31 13F INNOVIVA COM 45781M101 576,290 20,746 3.73 7,255 23.91 0.0039
2016-02-12 2015-12-31 13F THERAVANCE COM 88338T104 555,544 9,237 1.69 5,855 49.29 0.0033
2015-11-13 2015-09-30 13F THERAVANCE COM 88338T104 546,307 13,268 2.49 3,922 -59.28 0.0024
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 533,039 19,707 3.84 9,632 19.37 0.0055
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 513,332 9,763 1.94 8,069 13.25 0.0046
2015-02-12 2014-12-31 13F THERAVANCE COM 88338T104 503,569 26,096 5.47 7,125 -12.68 0.0042
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 477,473 20,771 4.55 8,160 -40.00 0.0053
2014-08-13 2014-06-30 13F THERAVANCE COM 88338T104 456,702 63,348 16.10 13,600 11.75 0.0088
2014-05-14 2014-03-31 13F THERAVANCE COM 88338T104 393,354 12,840 3.37 12,170 -10.28 0.0082
2014-02-14 2013-12-31 13F THERAVANCE COM 88338T104 380,514 68,593 21.99 13,565 6.36 0.0094
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 311,921 21,393 7.36 12,754 13.94 0.0102
2013-08-14 2013-06-30 13F THERAVANCE COM 88338T104 290,528 290,528 11,194 0.0098
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.